immune system
• mice infected with MERS-MA show mild inflammatory cell infiltrates in perivascular regions and alveolar septa at 1 and 3 days post infection (dpi), with mild and uncommon multifocal mononuclear cell infiltrates at 4 and 5 dpi
• mice infected with the parental MERS-CoV show mild inflammatory cell infiltrates in perivascular regions and alveolar septa at 1 and 3 dpi and multifocal mononuclear cell infiltrates at 4 and 5 dpi
• mice infected with MERS-MA show a greater accumulation of activated inflammatory monocyte-macrophages and neutrophils but fewer lymphocytes in the lungs than infection with MERS-CoV
• higher numbers of NK-, T-, and B-cells are seen in the lungs of MERS-CoV-infected mice compared to MERS-MA-infected mice
• both mice infected with MERS-MA and MERS-CoV exhibit an increase in reactive lymphocytes
|
• mice intranasally infected with 104-106 pfu Middle East respiratory syndrome coronavirus (MERS-CoV; EMC/2012, Vero 81 cell passaged)
• lung virus titers of mice infected with the mouse-adapted MERS-CoV, MERS-MA (obtained after 30 in vivo passages of the virus in mutant mice)
• mice infected with MERS-MA show weight loss, multifocal hyaline membranes, edema, and necrotic debris indicating diffuse alveolar damage
• mice infected with MERS-MA show delayed, but greater increases in type I and III interferons and more robust cytokine/chemokine responses that those infected with the parental MERS-CoV
• MERS-MA challenged mice show an overt and injurious innate inflammatory response and a suboptimal adaptive immune response
• lungs of mice infected with MERS-MA show lower absolute numbers of CD45+ leukocytes compared to MERS-CoV-infected mice or uninfected controls
• peripheral blood from MERS-MA-infected mice shows monocyte activation, reduced erythrocyte density, and reduced polychromatophils (immature RBCs) indicating anemia of inflammation
|
• after 21 in vivo passages of the MERS-CoV virus in mutant mice, virus inoculum causes approximate 50% mortality
• after 30 in vivo passages of the virus (the mouse-adapted MERS-CoV, MERS-MA) in mutant mice, a 104 pfu virus inoculum causes approximate 80% mortality
• mice inoculated with 105 pfu of MERS-MA plaque-purified isolates show fatal disease; an inoculum of 5 x 103 pfu is lethal
|
mortality/aging
• after 21 in vivo passages of the MERS-CoV virus in mutant mice, virus inoculum causes approximate 50% mortality
• after 30 in vivo passages of the virus (the mouse-adapted MERS-CoV, MERS-MA) in mutant mice, a 104 pfu virus inoculum causes approximate 80% mortality
• mice inoculated with 105 pfu of MERS-MA plaque-purified isolates show fatal disease; an inoculum of 5 x 103 pfu is lethal
|
respiratory system
• mice infected with MERS-MA develop pulmonary edema
|
• mice infected with MERS-MA show mild inflammatory cell infiltrates in perivascular regions and alveolar septa at 1 and 3 days post infection (dpi), with mild and uncommon multifocal mononuclear cell infiltrates at 4 and 5 dpi
• mice infected with the parental MERS-CoV show mild inflammatory cell infiltrates in perivascular regions and alveolar septa at 1 and 3 dpi and multifocal mononuclear cell infiltrates at 4 and 5 dpi
• mice infected with MERS-MA show a greater accumulation of activated inflammatory monocyte-macrophages and neutrophils but fewer lymphocytes in the lungs than infection with MERS-CoV
• higher numbers of NK-, T-, and B-cells are seen in the lungs of MERS-CoV-infected mice compared to MERS-MA-infected mice
• both mice infected with MERS-MA and MERS-CoV exhibit an increase in reactive lymphocytes
|
• mice infected with MERS-MA show multifocal hyaline membranes
|
cardiovascular system
• MERS-MA infected lungs show increased vascular permeability at 4 and 5 dpi
|
homeostasis/metabolism
• mice infected with MERS-MA develop pulmonary edema
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Middle East respiratory syndrome | DOID:0080642 | J:242025 |